Skip to main content

Articles

Page 3 of 8

  1. Advances in musculoskeletal (MSK) research have been successfully curated into widely endorsed evidence-based recommendations and guidelines. However, there continues to exist significant variations in care an...

    Authors: Opeyemi O. Babatunde, Shoba Dawson, June Brammar, Linda Parton, Krysia Dziedzic and Adewale O. Adebajo
    Citation: BMC Rheumatology 2022 6:84
  2. Rheuma Tolerance for Cure (RTCure) is a five-year international collaboration between academia, industry and patients/members of the public. It focuses on developing approaches to predict the onset of rheumato...

    Authors: Savia de Souza, Eva C. Johansson, Susanne Karlfeldt, Karim Raza and Ruth Williams
    Citation: BMC Rheumatology 2022 6:83
  3. Compared to the healthy population, the psychological impact of rheumatoid arthritis(RA) on patients' lives could dramatically lower their oral health-related quality of life (OHRQoL). Our goal is to analyze O...

    Authors: Amirhossein Parsaei, Aida Mehdipour, Hamidreza Ghadimi, Ashkan Mohammadi Kooshki, Parisa Shajari, Maryam Masoumi, Pouya Torabi, Hossein Azizi, Behnam Amini, Hanie Karimi, Hojat Dehghanbanadaki, Mohammad Aghaali and Soroush Moradi
    Citation: BMC Rheumatology 2022 6:61
  4. There is scant research about laboratory monitoring in people taking conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) for rheumatic disease. Our objective was to conduct a scoping study...

    Authors: James J. Tsakas, David F. L. Liew, Cameron L. Adams, Catherine L. Hill, Susanna Proudman, Samuel Whittle, Rachelle Buchbinder and Philip C. Robinson
    Citation: BMC Rheumatology 2022 6:59
  5. For many children and young people (CYP) with paediatric rheumatic conditions, glucocorticoid medications and their associated side-effects have a substantial impact on disease experience. Whilst there are phy...

    Authors: S. Singhal, E. M. D. Smith, L. Roper and C. E. Pain
    Citation: BMC Rheumatology 2022 6:80
  6. A treat-to-target (T2T) approach, where treatment is escalated until a specific target is achieved, and re-escalated if the target is lost, has been proposed as a strategy to improve Childhood Systemic Lupus E...

    Authors: R. S. Elliott, E. Taylor, J. Ainsworth, J. Preston and E. M. D. S. Smith
    Citation: BMC Rheumatology 2022 6:69
  7. This longitudinal study investigated whether changes in autonomous and controlled motivation to reduce sedentary behaviour were associated with variability in sedentary, standing and stepping time and, in turn...

    Authors: Ciara M. O’Brien, Joan L. Duda, George D. Kitas, Jet J. C. S. Veldhuijzen van Zanten, George S. Metsios and Sally A. M. Fenton
    Citation: BMC Rheumatology 2022 6:58
  8. Empirical evidence for effective patient-researcher collaboration in basic research is lacking. This study aims to explore good working models and impact of patient involvement in basic rheumatology research a...

    Authors: Maarten P. T. de Wit, M. I. Koenders, Y. Neijland, F. H. J. van den Hoogen, P. M. van der Kraan, F. A. J. van de Loo, H. Berkers, M. Lieon, A. van Caam and C. van den Ende
    Citation: BMC Rheumatology 2022 6:66
  9. Gout may be associated with an increased incidence of mental health disorders, however, published findings have been limited and inconsistent. Therefore, our objective was to conduct a population-based cohort ...

    Authors: Alyssa Howren, Eric C. Sayre, Hyon K. Choi, J. Antonio Avina-Zubieta, Kam Shojania, Jamie Y. Park and Mary A. De Vera
    Citation: BMC Rheumatology 2022 6:56
  10. JAK inhibitors are a relatively new class of medications that may be useful in the treatment of moderate-to-severe psoriasis and psoriatic arthritis (PsA). The objective of this study was to determine the effi...

    Authors: Samantha Sarabia, Brandan Ranjith, Sahil Koppikar and Don Thiwanka Wijeratne
    Citation: BMC Rheumatology 2022 6:71
  11. Osteoarthritis is associated with obesity, dyslipidemia and cardiovascular diseases. It has been hypothesized that L-carnitine can improve cardiovascular risk factors. We aimed to investigate the effect of L-c...

    Authors: Abbas Ali Sangouni, Farnaz Baghban, Maryam Khosravi, Hassan Mozaffari-Khosravi, Ali Dehghan and Mahdieh Hosseinzadeh
    Citation: BMC Rheumatology 2022 6:53
  12. Biologics have demonstrated efficacy in PsA in randomized clinical trials. More evidence is needed on their effectiveness under real clinical practice conditions. The aim of the present work is to provide real...

    Authors: Delia Colombo, Micol Frassi, Giusy Pagano Mariano, Enrico Fusaro, Claudia Lomater, Patrizia Del Medico, Florenzo Iannone, Rosario Foti, Massimiliano Limonta, Antonio Marchesoni, Bernd Raffeiner, Ombretta Viapiana, Walter Grassi, Rosa Daniela Grembiale, Giuliana Guggino, Antonino Mazzone…
    Citation: BMC Rheumatology 2022 6:57
  13. The rapid spread of COVID-19 required swift action to provide people with rheumatic and musculoskeletal diseases (RMDs) with reliable information. People with limited health literacy constitute a vulnerable gr...

    Authors: Mark Matthijs Bakker, Tess Luttikhuis, Polina Putrik, Isabelle Jansen, Jany Rademakers, Maarten de Wit and Annelies Boonen
    Citation: BMC Rheumatology 2022 6:52
  14. Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post-hoc analysis of two phase III studies in patients with PsA treated with tofacitinib assessed dactylitis b...

    Authors: Ana-Maria Orbai, Philip J. Mease, Philip S. Helliwell, Oliver FitzGerald, Dona L. Fleishaker, Rajiv Mundayat and Pamela Young
    Citation: BMC Rheumatology 2022 6:68
  15. Fibromyalgia (FM) as a prototypical nociplastic pain condition displays a difficult therapeutic situation in many cases. Given the promising data on the effect of vitamin B12 in improving pain and cognitive fu...

    Authors: Faeze Gharibpoor, Banafsheh Ghavidel-Parsa, Nazila Sattari, Ali Bidari, Fatemeh Nejatifar and Ali Montazeri
    Citation: BMC Rheumatology 2022 6:51
  16. Authors: Shereen Paramalingam, Merrilee Needham, Sarah Harris, Susan O’Hanlon, Frank Mastaglia and Helen Keen
    Citation: BMC Rheumatology 2022 6:72

    The original article was published in BMC Rheumatology 2022 6:47

  17. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome) is a recently described syndrome caused by a somatic missense variant at the methionine-41 (p.(Met41)) position in the ubiquit...

    Authors: Matheus V. M. B. Wilke, Eva Morava-Kozicz, Matthew J. Koster, Christopher T. Schmitz, Shannon Kaye Foster, Mrinal Patnaik, Kenneth J. Warrington, Eric W. Klee and Filippo Pinto e Vairo
    Citation: BMC Rheumatology 2022 6:54
  18. Rheumatoid arthritis (RA) is a chronic inflammatory arthritis which can cause joint damage and reduced quality of life. Early treatment of RA within 3 months of symptom onset is associated with improved clinic...

    Authors: Gwenda Simons, Nour Ismail, Karanbir Sandhu, Christian D. Mallen, Rebecca J. Stack, Sarah Pontefract, Karim Raza and Marie Falahee
    Citation: BMC Rheumatology 2022 6:50
  19. Psoriatic arthritis can cause pain, disability, and permanent joint damage. This can lead to impairments in work and social participation. Little is known about the extent of these impairments in routine pract...

    Authors: Tamara W. van Hal, Michelle L. M. Mulder, Mark H. Wenink and Johanna E. Vriezekolk
    Citation: BMC Rheumatology 2022 6:49
  20. Skin thickness is a prominent clinical feature of systemic sclerosis (SSc), but there is no consensus on the cut-off for a positive tuberculin skin test (TST) size and the limitation of the TST for a diagnosis...

    Authors: Apichart So-ngern, Ajanee Mahakkanukrauh, Siraphop Suwannaroj, Ratanavadee Nanagara and Chingching Foocharoen
    Citation: BMC Rheumatology 2022 6:48
  21. Research priority setting is a useful approach to decide which unanswered questions are most worth trying to solve through research. The aim is to reduce bias in the research agenda. Traditionally, research wa...

    Authors: Emma R. Dorris, Stacey Grealis, Karmen Kegl, Norelee Kennedy, Louise Larkin, Brian Lynch, Ailis Moran, Justine O’Brien, Stephanie Skeffington, Kayleigh Slater, Rebecca Ward and Allison Willett
    Citation: BMC Rheumatology 2022 6:55
  22. B mode ultrasound (US) and shear wave elastography (SWE) are easily accessible imaging tools for idiopathic inflammatory myopathies (IIM) but require further validation against standard diagnostic procedures s...

    Authors: Shereen Paramalingam, Merrilee Needham, Sarah Harris, Susan O’Hanlon, Frank Mastaglia and Helen Keen
    Citation: BMC Rheumatology 2022 6:47

    The Correction to this article has been published in BMC Rheumatology 2022 6:72

  23. To develop and assess a prediction model for polymyalgia rheumatica (PMR) relapse within the first year of glucocorticoid (GC) treatment.

    Authors: Thomas E. Bolhuis, Diane Marsman, Frank H. J. van den Hoogen, Alfons A. den Broeder, Nathan den Broeder and Aatke van der Maas
    Citation: BMC Rheumatology 2022 6:45
  24. People living with axial Spondyloarthrtis (axSpA) have an increased risk of cardiovascular diseases, which can be reduced by regular physical activity (PA) and its subset of cardiorespiratory training (CRT). T...

    Authors: Anne-Kathrin Rausch Osthoff, Irina Nast and Karin Niedermann
    Citation: BMC Rheumatology 2022 6:40
  25. Raynaud’s phenomenon is common condition, but little is known about the natural course. The primary aim of this study was to determine the incidence, remission, and persistence proportions of Raynaud’s phenome...

    Authors: Albin Stjernbrandt, Hans Pettersson, Ronnie Lundström, Ingrid Liljelind, Tohr Nilsson and Jens Wahlström
    Citation: BMC Rheumatology 2022 6:41
  26. Autoimmune disease following COVID-19 has been studied intensely since the beginning of the pandemic. Growing evidence indicates that SARS-CoV-2 infection, by virtue of molecular mimicry can lead to an antigen...

    Authors: Karolina Anderle, Klaus Machold, Hans P. Kiener, Daniel Bormann, Konrad Hoetzenecker, Silvana Geleff, Helmut Prosch, Franco Laccone, Peter M. Heil, Peter Petzelbauer, Daniel Aletaha, Stephan Blüml and Kastriot Kastrati
    Citation: BMC Rheumatology 2022 6:42
  27. Neuropsychiatric (NP) involvement and fatigue are major problems in systemic lupus erythematosus (SLE). S100A8/A9 is a marker of inflammation and responds to therapy in SLE patients. S100A8/A9 has an immunopat...

    Authors: Kristoffer A. Zervides, Andreas Jern, Jessika Nystedt, Birgitta Gullstrand, Petra C. Nilsson, Pia C. Sundgren, Anders A. Bengtsson and Andreas Jönsen
    Citation: BMC Rheumatology 2022 6:38
  28. During the first UK COVID-19 lockdown, studies identified over half of inflammatory arthritis (IA) patients in the UK reported a worsening of emotional distress. Given the prolonged nature of the pandemic, and...

    Authors: Emma Caton, Hema Chaplin, Lewis Carpenter, Melissa Sweeney, Hsiu Yen Tung, Savia de Souza, James Galloway, Elena Nikiphorou and Sam Norton
    Citation: BMC Rheumatology 2022 6:37
  29. To develop an interdisciplinary care pathway for early rheumatoid arthritis (RA) including referral triage, diagnosis, and management.

    Authors: Xenia Gukova, Glen S. Hazlewood, Hector Arbillaga, Paul MacMullan, Gabrielle L. Zimmermann, Cheryl Barnabe, May Y. Choi, Megan R. W. Barber, Alexandra Charlton, Becky Job, Kelly Osinski, Nicole M. S. Hartfeld, Marlene W. Knott, Paris Pirani and Claire E. H. Barber
    Citation: BMC Rheumatology 2022 6:35
  30. We conducted this study to identify the influence of prolonged use of hydroxychloroquine (HCQ), glucocorticoids and other immunosuppressants (IS) on occurrence and outcome of COVID-19 in patients with autoimmu...

    Authors: Abhishek Patil, K. Chanakya, Padmanabha Shenoy, S. Chandrashekara, Vikram Haridas, Sharath Kumar, Manisha Daware, Ramya Janardana, Benzeeta Pinto, Ramaswamy Subramanian, S. Nagaraj, Yogesh Preet Singh, Shweta Singhai, Ramesh Jois, Vikramraj Jain, C. Srinivasa…
    Citation: BMC Rheumatology 2022 6:32
  31. The gold standard for skin thickness assessment in systemic sclerosis (SSc) is the modified Rodnan skin score (mRSS); however, inter- and intra-rater variation can arise due to subjective methods and inexperie...

    Authors: Patnarin Pongkulkiat, Bandit Thinkhamrop, Ajanee Mahakkanukrauh, Siraphop Suwannaroj and Chingching Foocharoen
    Citation: BMC Rheumatology 2022 6:33
  32. Gout and diabetes mellitus type 2 (DM) frequently co-exist. The pharmacological effects of metformin may include anti-inflammatory and urate lowering effects. The objective of this study was to test these effe...

    Authors: Frouwke Veenstra, Lise M. Verhoef, Merel Opdam, Alfons A. den Broeder, Wing-Yee Kwok, Inger L. Meek, Cornelia H. M. van den Ende, Marcel Flendrie and Noortje van Herwaarden
    Citation: BMC Rheumatology 2022 6:27
  33. To evaluate the efficacy for symptomatic knee and hip osteoarthritis (OA) patients of a mindfulness-based stress reduction (MBSR) program versus usual care.

    Authors: Clémentine Marais, Yujie Song, Rosanna Ferreira, Safa Aounti, Claire Duflos, Grégory Baptista and Yves-Marie Pers
    Citation: BMC Rheumatology 2022 6:46
  34. There is increasing knowledge of how individual lifestyle factors affect patients with spondyloarthritis, while studies exploring the combination of unhealthy lifestyle factors are lacking. Thus, our aim was t...

    Authors: Elisabeth Mogard, Ann Bremander and Emma Haglund
    Citation: BMC Rheumatology 2022 6:29
  35. POEMS syndrome is a rare paraneoplastic syndrome caused by plasma cell disorder almost always lambda restricted. Secondary Raynaud’s phenomenon is an overlooked skin manifestation of the disease even though it...

    Authors: Fabio Torres-Saavedra and Lina León-Sierra
    Citation: BMC Rheumatology 2022 6:26
  36. This pilot study’s primary aim was to determine if oligoclonal B cell expansion in children with Juvenile Dermatomyositis (JDM) predicts response to Rituximab therapy. We evaluated: (1) tissue B cell depletion...

    Authors: Elisa Ochfeld, Victoria Hans, Wil Marin, Najah Ahsan, Gabrielle Morgan, Lauren M. Pachman and Amer Khojah
    Citation: BMC Rheumatology 2022 6:36
  37. The Invalidation Illness Inventory (3*I) is an instrument that assesses invalidation (including discounting and lack of understanding dimensions) experienced by patients with rheumatic disorders. This study ai...

    Authors: Banafsheh Ghavidel-Parsa, Mohammad-Javad Khosousi, Sepehr Tohidi, Ali Bidari, Saman Soltani, Habib Zayeni and Ali Montazeri
    Citation: BMC Rheumatology 2022 6:23
  38. Rheumatoid arthritis (RA) is an inflammatory disease that is characterized by the overproduction of cytokines. Among the newly discovered cytokines are the adipokines which are primarily produced by and releas...

    Authors: Marjan Taherian, Simin Almasi, Saber Mehdizadeh, Banafshe Fazeli, Mahsa Kalantari, Paria Bayati, Salar Pashangzadeh and Nazanin Mojtabavi
    Citation: BMC Rheumatology 2022 6:25
  39. Previous research has provided evidence for cognitive dysfunction as a common symptom of systemic lupus erythematosus (SLE). In light of this, the primary goal of this study was to investigate how cognitive im...

    Authors: L. Langensee, J. Mårtensson, A. Jönsen, K. Zervides, A. Bengtsson, J. Nystedt, B. Cannerfelt, P. Nilsson, P. Mannfolk, J. Lätt, T. Rumetshofer and P. C. Sundgren
    Citation: BMC Rheumatology 2022 6:22
  40. Rheumatoid arthritis (RA) is a heterogeneous disease with established poor prognostic factors such as seropositivity, joint damage, and high disease activity at an early, treatment-naïve stage of disease. Howe...

    Authors: Patrick Durez, Rene Westhovens, Femke Baeke, Yedid Elbez, Sofie Robert and Harris A. Ahmad
    Citation: BMC Rheumatology 2022 6:24
  41. Studying health-related quality of life (HRQoL) and treatment satisfaction have helped in understanding how to optimize rheumatoid arthritis (RA) treatment outcomes and find ways to alleviate signs and symptom...

    Authors: Heba Abu Hamdeh, Samah W. Al-Jabi, Amer Koni and Sa’ed H. Zyoud
    Citation: BMC Rheumatology 2022 6:19
  42. Dermatomyositis belongs to an infrequent group of diseases predominantly found in patients older than 40 years old and is characterized by dermal and muscular findings. This disease presents itself as proximal...

    Authors: Adolfo Camargo Coronel, Francisco Javier Jiménez Balderas, Horacio Quiñones Moya, Mario Raúl Hernández Zavala, Pedro Mandinabeitia Rodríguez, José Ramiro Hernández Vázquez, Sandy Zamora Zarco and Sergio De Jesús Aguilar Castillo
    Citation: BMC Rheumatology 2022 6:20

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.1
    5-year Journal Impact Factor: 2.5
    Source Normalized Impact per Paper (SNIP): 0.776
    SCImago Journal Rank (SJR): 0.805

    Speed 2023
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 247

    Usage 2023
    Downloads: 398,220
    Altmetric mentions: 294

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal